Cyproterone
Sold as Androcur, Cyproplex, Cipla-cyproterone acetate, Androfem, Androcur depot
[(1S,2S,3S,5R,11R,12S,15R,16S)-15-Acetyl-9-chloro-2,16-dimethyl-6-oxo-15-pentacyclo[9.7.0.02,8.03,5.012,16]octadeca-7,9-dienyl] acetate
Drag to rotate. Structure from PubChem CID 9880.
Background
Registration
- Applicants
- 4
- Registrations
- 8
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharmaco Distribution (Pty) LtdCertificate held by Bayer (Pty) Ltd | Androcur, Androcur depot | 50 mg, 100 mg, 300 mg | 290515, R0160, R0184 | S4 | PIPIL |
| Teva Pharmaceuticals (Pty) LtdCancelled | Cyproplex | 50 mg | 350155 | S4 | None |
| Cipla Medpro (Pty) Ltd1 of 3 cancelled | Cipla-cyproterone acetate, Androfem | 50, 100 | 350293, 360167, A390629 | S4 | None |
| Bayer (Pty) Ltd û IsandoCancelled | Androcur | 10 mg | R0159 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Androcur 100 MG EACH TABLET CONTAINS CYPROTERONE ACETATE 100,0 mg | 100 mg | 29051529/21.12/0515 | Registered | S4 | None |
| Cyproplex 50 MG EACH TABLET CONTAINS CYPROTERONE ACETATE 50,0 mg | 50 mg | 35015535/21.12/0155 | Cancelled | S4 | None |
| Cipla-cyproterone acetate 50 EACH TABLET CONTAINS CYPROTERONE ACETATE 50,0 mg | 50 | 35029335/21.12/0293 | Registered | S4 | None |
| Androfem EACH TABLET CONTAINS CYPROTERONE ACETATE 50,0 mg | Not listed | 36016736/21.12/0167 | Registered | S4 | None |
| Androfem 100 EACH TABLET CONTAINS CYPROTERONE ACETATE 100,0 mg | 100 | A390629A39/21.12/0629 | Cancelled | S4 | None |
| Androcur 10 MG tablets EACH TABLET CONTAINS CYPROTERONE ACETATE 10 mg | 10 mgTablets | R0159R/21.12/159 | Cancelled | S4 | None |
| Androcur 50 MG tablets EACH TABLET CONTAINS CYPROTERONE ACETATE 50 mg | 50 mgTablets | R0160R/21.12/160 | Registered | S4 | None |
| Androcur depot EACH 3 ml OILY SOLUTION CONTAINS CYPROTERONE ACETATE 300 mg | 300 mgSolution for injection | R0184R/21.12/184Approved 14 December 2021 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Cyproterone acetate
S4: Cyproterone acetate
Consolidated Schedules 06 July 2026, line 5916
Pharmacological class: Hormone inhibitors. (class 21.12)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Androcur depot, Pharmaco Distribution (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.